Follow the latest coverage, related explainers and connected technology stories.
The U.S. Food and Drug Administration has authorized Vitestro’s Aletta, a robotic system that uses imaging, ultrasound, and artificial intelligence to draw blood samples without direct manual intervention by a specialist throughout the procedure. The device may allow one specialist to supervise up to three devices at a time, as the United States faces a shortage of workers trained in blood collection.
The FDA has authorized Vitestro’s Aletta device, the first autonomous robotic device of its kind to draw blood from a patient’s arm without direct manual intervention during the procedure. Its use is currently limited to adults in outpatient clinics, with every session remaining under the supervision of a professional trained in blood collection.